|
2024 Journal Article Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trialStewart, Adam G., Harris, Patrick N.A., Graham, Rikki M.A., Jennison, Amy V., Schlebusch, Sanmarie, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2024). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Pathology, 56, S36-S37. doi: 10.1016/j.pathol.2023.12.137 |
|
2024 Journal Article Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsisHarris, Patrick N. A., Bauer, Michelle J., Lüftinger, Lukas, Beisken, Stephan, Forde, Brian M., Balch, Ross, Cotta, Menino, Schlapbach, Luregn, Raman, Sainath, Shekar, Kiran, Kruger, Peter, Lipman, Jeff, Bialasiewicz, Seweryn, Coin, Lachlan, Roberts, Jason A., Paterson, David L. and Irwin, Adam D. (2024). Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis. Microbiology Spectrum, 12 (2) e0306523, 1-16. doi: 10.1128/spectrum.03065-23 |
|
2024 Journal Article Vibrio species bloodstream infections in Queensland, AustraliaDavidson, Natalie, Edwards, Felicity, Harris, Patrick N.A. and Laupland, Kevin B. (2024). Vibrio species bloodstream infections in Queensland, Australia. Internal Medicine Journal, 54 (1), 157-163. doi: 10.1111/imj.16187 |
|
2024 Journal Article Mortality, hospital length of stay and recurrent bloodstream infections associated with extended-spectrum beta-lactamase producing Escherichia coli (ESBL-Ec) in a low prevalence region: a 20-year population-based large cohort studyLing, Weiping, Paterson, David L., Harris, Patrick N. A., Furuya-Kanamori, Luis, Edwards, Felicity and Laupland, Kevin B. (2024). Mortality, hospital length of stay and recurrent bloodstream infections associated with extended-spectrum beta-lactamase producing Escherichia coli (ESBL-Ec) in a low prevalence region: a 20-year population-based large cohort study. International Journal of Infectious Diseases, 138, 84-90. doi: 10.1016/j.ijid.2023.11.007 |
|
2024 Journal Article Host response signature trends in bacteraemia–authors’ responsePeri, Anna Maria, Harris, Patrick N. A. and Paterson, David L. (2024). Host response signature trends in bacteraemia–authors’ response. Infectious Diseases, 56 (5), 1-3. doi: 10.1080/23744235.2024.2326591 |
|
2023 Journal Article Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational studyPeri, Anna Maria, Rafiei, Nastaran, O’Callaghan, Kevin, Brischetto, Anna, Graves, Bianca, Sinclair, Holly, Eustace, Matthew, Lim, Karen, Parkes-Smith, Jill, Stewart, Adam, Davidson, Natalie, Tabah, Alexis, Bergh, Haakon, Chatfield, Mark D., Harris, Patrick N. A. and Paterson, David L. (2023). Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study. Infectious Diseases, 56 (4), 268-276. doi: 10.1080/23744235.2023.2294122 |
|
2023 Journal Article Evaluation of Illumina® COVIDSeq™ as a Tool for Omicron SARS-CoV-2 CharacterisationLowry, Kym, Bauer, Michelle J., Buckley, Cameron, Wang, Claire, Bordin, Amanda, Badman, Steven, Harris, Patrick N.A., Mackay, Ian and Whiley, David (2023). Evaluation of Illumina® COVIDSeq™ as a Tool for Omicron SARS-CoV-2 Characterisation. Journal of Virological Methods, 322 114827, 1-5. doi: 10.1016/j.jviromet.2023.114827 |
|
2023 Journal Article Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesTamma, Pranita D., Harris, Patrick N. A., Mathers, Amy J., Wenzler, Eric and Humphries, Romney M. (2023). Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales. Clinical Infectious Diseases, 77 (11), 1585-1590. doi: 10.1093/cid/ciac688 |
|
2023 Conference Publication Elizabethkingia species: an emerging cause of healthcare-associated bloodstream infection among immunocompromised hostsStewart, Adam, Laupland, Kevin, Edwards, Felicity, Paterson, David and Harris, Patrick N. A. (2023). Elizabethkingia species: an emerging cause of healthcare-associated bloodstream infection among immunocompromised hosts. IDWeek 2023, Boston, MA USA, 11-15 October 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofad500.310 |
|
2023 Conference Publication Assessment of in vitro synergy between piperacillin-tazobactam-meropenem and imipenem-meropenem against OXA-48 producing Klebsiella pneumoniae using time-kill assaysDemir, Mervenur, Aslan, Abdullah Tarik, Seren Tanrıverdi, Elif, Otlu, Barış, Akova, Murat, Paterson, David, Harris, Patrick N. A. and Hazırolan, Gülşen (2023). Assessment of in vitro synergy between piperacillin-tazobactam-meropenem and imipenem-meropenem against OXA-48 producing Klebsiella pneumoniae using time-kill assays. IDWeek 2023, Boston, MA USA, 11-15 October 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofad500.2357 |
|
2023 Conference Publication A comparison of low-level to high-level disinfection in eliminating microorganisms from ultrasound transducers used on skin: a non-inferiority randomised controlled trialPeters, Nathan, Williamson, Frances, Bauer, Michelle, Llewellyn, Stacey, Snelling, Peter, Marsh, Nicole, Harris, Patrick, Stewart, Adam and Rickard, Claire (2023). A comparison of low-level to high-level disinfection in eliminating microorganisms from ultrasound transducers used on skin: a non-inferiority randomised controlled trial. 2023 ACIPC International Conference, Adelaide, SA Australia, 12-15 November 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.idh.2023.09.002 |
|
2023 Journal Article The opportunities and challenges for artificial intelligence to improve sepsis outcomes in the paediatric intensive care unitAslan, Abdullah Tarik, Permana, Budi, Harris, Patrick N. A., Naidoo, Kuban D., Pienaar, Michael A. and Irwin, Adam D. (2023). The opportunities and challenges for artificial intelligence to improve sepsis outcomes in the paediatric intensive care unit. Current Infectious Disease Reports, 25 (11), 243-253. doi: 10.1007/s11908-023-00818-4 |
|
2023 Journal Article Bugs in floodsBlaskovich, Mark A. T. and Harris, Patrick N. A. (2023). Bugs in floods. Microbiology Australia, 44 (4), 176-180. doi: 10.1071/ma23051 |
|
2023 Journal Article Melioidosis Queensland: an analysis of clinical outcomes and genomic factorsGassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Norton, Robert and Harris, Patrick N. A. (2023). Melioidosis Queensland: an analysis of clinical outcomes and genomic factors. PLoS Neglected Tropical Diseases, 17 (10) e0011697, 1-13. doi: 10.1371/journal.pntd.0011697 |
|
2023 Journal Article Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 yearsPeri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x |
|
2023 Journal Article In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping reviewAslan, Abdullah Tarık, Ezure, Yukiko, Horcajada, Juan Pablo, Harris, Patrick N. A. and Paterson, David L. (2023). In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Frontiers in Medicine, 10 1249030, 1-16. doi: 10.3389/fmed.2023.1249030 |
|
2023 Journal Article Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancyStewart, Adam G., Heney, Claire, Paterson, David L., Harris, Patrick N.A., Edwards, Felicity and Laupland, Kevin B. (2023). Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy. Internal Medicine Journal, 53 (8), 1489-1491. doi: 10.1111/imj.16198 |
|
2023 Journal Article Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpointsIsler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem, Akova, Murat ... Harris, Patrick N. A. (2023). Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints. Infectious Diseases, 55 (9), 607-613. doi: 10.1080/23744235.2023.2226709 |
|
2023 Journal Article Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trialRogers, Benjamin A., Fowler, Robert, Harris, Patrick N. A., Davis, Joshua S., Pinto, Ruxandra L., Bhatia Dwivedi, Dhiraj, Rishu, Asgar, Shehabi, Yahya and Daneman, Nick (2023). Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial. BMJ Open, 13 (6) e069708. doi: 10.1136/bmjopen-2022-069708 |
|
2023 Journal Article Comparison of low‐level to high‐level disinfection in eliminating microorganisms from ultrasound transducers used on skin : a noninferiority randomized controlled trialPeters, Nathan, Williamson, Frances, Bauer, Michelle J., Llewellyn, Stacey, Snelling, Peter J., Marsh, Nicole, Harris, Patrick N. A., Stewart, Adam G. and Rickard, Claire M. (2023). Comparison of low‐level to high‐level disinfection in eliminating microorganisms from ultrasound transducers used on skin : a noninferiority randomized controlled trial. Journal of Ultrasound in Medicine, 42 (11), 2525-2534. doi: 10.1002/jum.16286 |
